Back
Janux Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
JANX
Janux Therapeutics, Inc.
Last Price:
$14.05
Seasonality Move:
45.56%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing slight buying pressure.
Janux Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.28 | Buy |
| 20-day SMA: | 18.07 | Sell |
| 50-day SMA: | 24.08 | Sell |
| 200-day SMA: | 25.34 | Sell |
| 8-day EMA: | 14.63 | Sell |
| 20-day EMA: | 17.62 | Sell |
| 50-day EMA: | 21.62 | Sell |
| 200-day EMA: | 26.79 | Sell |
Janux Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.31 | Sell |
| Relative Strength Index (14 RSI): | 28.97 | Sell |
| Chaikin Money Flow: | 220796 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.59 - 28.53) | Sell |
| Bollinger Bands (100): | (19.22 - 28.82) | Sell |
Janux Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics, Inc. Stock
Is Janux Therapeutics, Inc. Stock a Buy?
-
Janux Therapeutics, Inc. share price is 14.31 while JANX 8-day simple moving average is 14.28, which is a Buy signal.
-
The stock price of JANX is 14.31 while Janux Therapeutics, Inc. 20-day SMA is 18.07, which makes it a Sell.
-
Janux Therapeutics, Inc. 50-day simple moving average is 24.08 while JANX share price is 14.31, making it a Sell technically.
-
JANX stock price is 14.31 and Janux Therapeutics, Inc. 200-day simple moving average is 25.34, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
38
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. a Buy or a Sell?
-
Janux Therapeutics, Inc. stock is rated a SellThe current Janux Therapeutics, Inc. [JANX] share price is $14.31. The Score for JANX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics, Inc. Stock Info
Market Cap:
860.7M
Price in USD:
14.31
Share Volume:
1.5M
Janux Therapeutics, Inc. 52-Week Range
52-Week High:
61.59
52-Week Low:
13.76
Sell
38
Janux Therapeutics, Inc. (JANX)
is a Sell
Janux Therapeutics, Inc. Share Price Forecast
-
What is the Janux Therapeutics, Inc. stock price today?The Janux Therapeutics, Inc. stock price is 14.31 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics, Inc. is overvalued.
Is Janux Therapeutics, Inc. Stock a Buy?
-
Janux Therapeutics, Inc. share price is 14.31 while JANX 8-day exponential moving average is 14.63, which is a Sell signal.
-
The stock price of JANX is 14.31 while Janux Therapeutics, Inc. 20-day EMA is 17.62, which makes it a Sell.
-
Janux Therapeutics, Inc. 50-day exponential moving average is 21.62 while JANX share price is 14.31, making it a Sell technically.
-
JANX stock price is 14.31 and Janux Therapeutics, Inc. 200-day simple moving average is 26.79, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics, Inc.
Is Janux Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and a decrease next year of $1.00 per share.
Technical Analysis of Janux Therapeutics, Inc.
Should I short Janux Therapeutics, Inc. stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is -3.31, suggesting Janux Therapeutics, Inc. is a Sell
-
Janux Therapeutics, Inc. Relative Strength Index (RSI) is 28.97, which suggest Janux Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Janux Therapeutics, Inc. is (12.59 - 28.53), which suggest Janux Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics, Inc. is (19.22 - 28.82), which suggest Janux Therapeutics, Inc. is a Sell
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.